Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/1990
05/29/1990US4929554 Human immune interferon
05/29/1990US4929442 Compositions suitable for human topical application including a growth factor and/or related materials
05/25/1990CA2003868A1 Process for the synthesis of novel and known nitroimidazoles which are useful as sensitizing agents
05/23/1990EP0369944A1 Substituted oxadiamino butanes
05/23/1990EP0369943A1 Binding protein for insulin-like growth factors
05/23/1990EP0369749A2 Anti-Tumor Compounds
05/23/1990EP0369696A2 Quinolizine sulfonamides as antineoplastic agents
05/23/1990EP0369409A1 Carbocyclic nucleosides and nucleotides
05/23/1990EP0369182A1 Antitumour saccharide conjugates
05/23/1990EP0369000A1 Macrocyclic complexes of yttrium, the lanthanides and the actinides having peripheral coupling functionalities
05/23/1990CN1042377A Process for preparing non-glycosylated recombining human il2 in reduced form
05/23/1990CN1042376A Nutritive liquid
05/23/1990CN1042362A Process for producing sugar phosphates and sulfonates of epipodophylotoxin glucosides
05/23/1990CN1042347A 2-aminocarboxylic acids and their derivatives, processes for their preparation and their use as medicaments
05/23/1990CN1008093B Process for preparation of isothiuronium salts compounds
05/23/1990CA2003719A1 Compounds
05/23/1990CA2003695A1 Position-specific insertion vectors and method of using same
05/22/1990US4927919 Chartreusin derivatives and salts thereof
05/22/1990US4927815 Homologs of 1,25-dihydroxyvitamin d3 as agents for the treatment of neoplastic diseases
05/22/1990US4927571 Preparation of injectable doxorubicin/liposome suspension
05/22/1990CA1269500A1 Muramyldipeptide active ester derivatives
05/22/1990CA1269395A1 Pharmaceutically active phosphino-hydrocarbon-group viii-metal complexes, antitumor compositions containing these complexes, and a process for preparing said compounds or antitumor compositions
05/22/1990CA1269370A1 Daunomycin and adriamycin sulfono and sulfoxo analogues
05/22/1990CA1269367A1 Sialosylcerebrosides and a preparation method thereof
05/21/1990CA2003537A1 Inhibitors for glycosaminosyl transferase v
05/21/1990CA2003350A1 Human neutrophilic granulocyte end-stage maturation factor and its preparation and use
05/18/1990CA2003091A1 Substituted oxadiaminobutanes
05/17/1990WO1990005180A1 Products and methods for controlling the suppression of the neoplastic phenotype
05/17/1990WO1990005147A1 Natural killer stimulatory factor
05/17/1990WO1990005142A1 Polypeptides
05/17/1990WO1990005130A1 2-aminocarboxylic acid derivatives, their manufacture and use as drugs
05/17/1990WO1990004966A2 Chemoprevention of electrophilic damage by mercaptopurine analogs
05/16/1990EP0368668A2 Antibody-drug conjugates
05/16/1990EP0368486A2 Novel inhibitors of platelet binding
05/16/1990EP0368367A1 Purification, production and use of tumor necrosis factors
05/16/1990EP0368223A2 Use of ethylene diamine tetraacetic acid as inhibitor of calcium/calmoduline-dependent protein kinase II or protein kinase C
05/16/1990EP0368131A2 Neoglucoproteins, their preparation and use
05/16/1990EP0367974A1 Cis-complexes with a 1,3-diaminopropane derivative as a ligand, methods for their preparation and pharmaceutical agents containing such complexes
05/16/1990CN1042147A Thiochroman esters of phenols and terephthallates having retinoid-like activity
05/16/1990CN1042075A Medicines for transcortical application containing steroidhormonen
05/16/1990CN1007958B Process for the preparation of metal complexes of bis-indole compounds and agueous pharmaceutical compositions containing them
05/15/1990US4925979 Flavone carboxylic acid derivatives
05/15/1990US4925793 Human immune interferon
05/15/1990US4925736 Dispersed in carrier vehicle capable of deep penetration of mammalian skin
05/15/1990US4925662 Antitumor agent bonded to human immunoglobulin
05/15/1990US4925658 Treatment of dermatologic, rheumatic, respiratory, ophthalmologic disorders
05/14/1990EP0345308A4 Ornithine derivatives and their use as inhibitors of methotrexate resistant cells.
05/14/1990CA2002869A1 Cloned genes which encode elam-1 and fusion proteins thereof, the protein products expressed therefrom, pharmaceutical compositions and the use thereof
05/14/1990CA2002860A1 Antibodies specific for elam-1 and the use thereof
05/14/1990CA2002853A1 Potent inducers of terminal differentiation and method of use thereof
05/11/1990CA2002609A1 Binding proteins for insulin-like growth factors
05/10/1990CA2441636A1 Natural killer stimulatory factor
05/10/1990CA2002637A1 Use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase c
05/10/1990CA2000821A1 Inhibitors of platelet binding
05/10/1990CA2000483A1 Antibody-drug conjugates
05/09/1990EP0367576A2 Estrogen nucleus derivatives for use in the inhibition of sex steroid activity
05/09/1990EP0367502A1 Methods of synthesizing benign prostatic hypertrophic agents
05/09/1990EP0367449A1 Mixed chalcogenide pyrylium salts of a Lewis base
05/09/1990EP0367223A2 Chelants possessing ortho ligating functionality and complexes thereof
05/09/1990EP0367205A1 2-Aminocarboxylic acids and their derivatives, methods for their preparation and their use as pharmaceutical compositions
05/09/1990EP0367189A2 Sugar phosphates and sulfonates of epipodophyllotoxin glucosides
05/08/1990US4924012 Process for preparing derivatives of baccatine III and of 10-deacetyl baccatine III
05/08/1990US4924011 Condensation, esterification; antitumor and anitleukemia agents
05/08/1990US4923878 Quinolizine sulfonamides used against certain neoplastic disease states
05/08/1990US4923871 Antitumor
05/08/1990US4923697 Antioxidant compositions and methods
05/08/1990CA1268900A1 Immunomodulators obtained by hemisynthesis of a bacterial polysaccharide isolated from a mutant strain of klebsiella pneumoniae
05/08/1990CA1268775A1 [2,2-bis(aminomethyl)-1,3-propanediol-n, n']platinum complexes
05/08/1990CA1268769A1 Thiazole sulfides and their use as immunomodulators
05/08/1990CA1268714A1 Use of an aqueous chlorite matrix solution for the treatment of tumors
05/07/1990CA2002352A1 Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides
05/03/1990WO1990004597A1 Tumor-inhibiting saccharide conjugates
05/03/1990WO1990004593A1 Desamino-aminopterin and -methotrexate
05/03/1990WO1990004415A1 Anti-idiotypic antibody induction of antitumor response
05/03/1990WO1990004413A1 ANTIBODY CONJUGATES WITH TWO OR MORE COVALENTLY LINKED Fc REGIONS
05/03/1990WO1990004412A1 Liposome immunoadjuvants containing il-2
05/03/1990WO1990004410A1 A novel family of high affinity, modified antibodies for cancer treatment
05/03/1990WO1990004408A1 Composition and treatment with biologically active peptides and certain anions
05/03/1990WO1990004407A1 Cpf peptide compositions and uses
05/03/1990WO1990004397A1 Preparation for transdermal application containing gestodene
05/03/1990WO1990004386A1 Orally pharmaceutical preparations with colon selective delivery
05/02/1990EP0366621A1 Orally pharmaceutical preparations with colon selective delivery
05/02/1990EP0366122A2 Demethylepipodophyllotoxin derivatives
05/02/1990EP0366061A1 Use of 4H-1-benzopyran-4-one derivatives, 4H-1-benzopyran-4-one derivatives and medicines containing same
05/02/1990EP0365997A2 A novel family of high affinity, modified antibodies for cancer treatment
05/02/1990EP0365973A1 Process for preparing 4-0-alkyl-rhodomycins
05/02/1990EP0365956A2 Carcinostatic agents
05/02/1990EP0365763A1 Antiproliferative cyclic compounds
05/02/1990CN1041695A Method for preparing pharmaceutical curative for veterinary and human medicine, with antiviral and antitumoral effect, including pharmaceutical form of application and said curative
05/01/1990US4921963 Platinum complexes with one radiosensitizing ligand
05/01/1990US4921849 Injection containing 3-benzoyloxy-1,3,5(10)-estratriene-17-[4-{p-(bis(2-chloroethyl)amino)phenyl}butanoyloxy)acetate as an active ingredient
05/01/1990US4921697 IFN-gamma as an active substance for inhibiting and preventing degradation processes in bone
05/01/1990CA1268599A1 Cis-platinum complexes with a pentaerythritol derivative as the ligand, a process for their preparation and a pharmaceutical agent containing these compounds
04/1990
04/30/1990CA2001938A1 Estrogen nucleus derivatives for use in the inhibition of sex steroid activity
04/27/1990CA2001494A1 Carcinostatic agents
04/25/1990EP0365421A1 Specific ligands for estrogenic and progestagenic steroidal hormone receptors, their use and synthesis intermediates
04/25/1990EP0364819A2 LHRH analogs
04/25/1990EP0364509A1 Cellular toxic conjugates
04/25/1990EP0364491A1 Stabilized formulations of gamma interferons
04/24/1990US4920140 Benzimidazole derivatives and their thereapeutic and cosmetic use
1 ... 2162 2163 2164 2165 2166 2167 2168 2169 2170 2171 2172 2173 2174 2175 2176 2177 2178 2179 2180 2181 2182 ... 2211